Loria, Paula M.

A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor

Griffith, D. A., Edmonds, D. J., Fortin, J.-P., Kalgutkar, A. S., Kuzmiski, J. B., Loria, P. M., Saxena, A. R., Bagley, S. W., Buckeridge, C., Curto, J. M., et al. (2022) · Journal of Medicinal Chemistry

Diabetes Treatment and ManagementReceptor Mechanisms and Signaling

Cited by 192

Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice

LeBrasseur, N. K., Schelhorn, T. M., Bernardo, B. L., Cosgrove, P. G., Loria, P. M., & Brown, T. A. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences

Muscle Physiology and DisordersCardiovascular and exercise physiology

Cited by 180

Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate

Bhattacharya, S. K., Andrews, K., Beveridge, R., Cameron, K. O., Chen, C., Dunn, M., Fernando, D., Gao, H., Hepworth, D., Jackson, V. M., et al. (2014) · ACS Medicinal Chemistry Letters

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 73